Are BLD (Blood), UBG (Urobilinogen), and BIL (Bilirubin) values of 10, 8, and 4 respectively considered high in a patient with a urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are These Urinalysis Values Considered High in a Patient with UTI?

Yes, blood (10), urobilinogen (8), and bilirubin (4) on urinalysis dipstick are all elevated and clinically significant in the context of a urinary tract infection, indicating both urinary tract inflammation with hematuria and potential systemic involvement with hepatorenal effects from the infection.

Understanding Each Abnormal Parameter

Blood (BLD) = 10

  • This represents significant hematuria (blood in urine), which is common in UTI and indicates urinary tract inflammation with mucosal injury 1
  • Hematuria is documented as a frequent finding in leptospirosis-associated UTI, where urinalysis shows proteinuria and hematuria together 1
  • In the context of fever and pyuria (which your patient likely has), hematuria supports the diagnosis of UTI/pyelonephritis requiring immediate culture and treatment 2

Urobilinogen (UBG) = 8

  • Normal urobilinogen is typically 0.2-1.0 mg/dL (or Ehrlich units 0.1-1.0), so a value of 8 is markedly elevated 3
  • However, isolated elevated urobilinogen has poor predictive value (only 68-72% accuracy) for detecting liver function abnormalities and should not be used alone as a screening test 3
  • Elevated urobilinogen in UTI context may reflect hemolysis from gram-negative bacterial infection (particularly E. coli), which is well-documented to cause hemolytic anemia with both direct and indirect bilirubin elevation 4

Bilirubin (BIL) = 4

  • Any positive urine bilirubin (>0) is abnormal, as normal urine contains no detectable bilirubin 1, 5
  • In infants with UTI, 7.5% present with jaundice as an early sign, with bilirubin levels ranging from 6-48.2 mg/dL 6
  • Gram-negative UTI (especially E. coli) causes hemolysis with elevation of both direct and indirect bilirubin fractions, documented in 24 infants with UTI presenting with jaundice 4
  • However, urine bilirubin has an 85% rate of correlating with abnormal liver function tests when unexpected positives occur, though it represents only 0.13% of all tests 5

Clinical Significance in UTI Context

Hemolysis from Gram-Negative Infection

  • E. coli UTI (the most common pathogen in 83% of cases) produces hemolysins that cause red blood cell destruction, leading to elevated urobilinogen and bilirubin 4, 7
  • All 11 tested E. coli isolates from jaundiced infants with UTI produced hemolysis on blood agar plates, confirming the hemolytic mechanism 4
  • BUN elevation (18-153 mg/dL) generally correlates with bilirubin elevation in these cases, suggesting hepatorenal involvement 4

Systemic Involvement Indicators

  • The combination of hematuria, elevated urobilinogen, and bilirubinuria suggests pyelonephritis with systemic effects rather than simple cystitis 1, 2
  • In leptospirosis (a differential for severe UTI), there may be biochemical evidence of renal failure with high bilirubin and mild transaminase elevation 1
  • Renal function tests should be monitored, as elevated bilirubin with UTI may indicate hepatorenal syndrome 1

Critical Management Implications

Immediate Actions Required

  • Obtain urine culture by catheterization before starting antibiotics to confirm pathogen and guide definitive therapy 2, 1
  • Start empiric antibiotics immediately after culture collection in this systemically ill patient with multiple abnormal parameters 2
  • Check complete blood count to assess for hemolytic anemia (hemoglobin, hematocrit, peripheral smear for hemolysis) 4
  • Obtain serum liver function tests (AST, ALT, GGT, total/direct bilirubin) and renal function tests (BUN, creatinine) to assess hepatorenal involvement 1, 5

Antibiotic Selection

  • First-line empiric options include cefazolin or cefuroxime for suspected E. coli (94-98% sensitive) 2
  • Alternative: trimethoprim-sulfamethoxazole for non-E. coli organisms (82.2% sensitive) 2
  • Avoid nitrofurantoin if creatinine clearance <30 mL/min given potential renal dysfunction 2

Common Pitfalls to Avoid

  • Do not dismiss elevated urobilinogen and bilirubin as "false positives" in the setting of confirmed UTI—these likely represent true hemolysis from gram-negative infection 4, 3
  • Do not delay antibiotics waiting for liver function test results—the combination of hematuria with bilirubinuria suggests severe infection requiring immediate treatment 2
  • Do not assume isolated lower UTI—these parameters suggest upper tract involvement (pyelonephritis) with systemic effects 1, 2
  • Do not forget to image the kidneys with renal ultrasound to exclude obstruction, hydronephrosis, or structural abnormalities, especially if fever persists beyond 72 hours 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Likelihood of Kidney Stone in Clinical Presentation with Fever and Pyuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemolysis due to gram-negative urinary tract infection.

Birth defects original article series, 1977

Research

Urinary tract infection and hyperbilirubinemia.

The Turkish journal of pediatrics, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.